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tions showed similar superiority for outcome parameters: dou-A new morphologic index for the evaluation of renal biopsies
bling of SCr (0.1810 vs. 0.3018) and end-stage renal diseasein lupus nephritis.
(0.0529 vs. 0.1925). The same improvement of correlations wasBackground. Various morphologic indices for the evalua-
tion of renal biopsies in lupus nephritis have been developed, seen at Bx2 for most parameters, particularly doubling of SCr
of which the most successful have been the NIH Activity Index (0.2716 vs. 0.4753).
(AI) and Chronicity Index (CI). We wished to develop a biopsy Conclusions. The Biopsy Index and/or its components show
index from standard light and immunofluorescence (IF) mate- better correlations with clinical and outcome parameters than
rial that would correlate yet more closely with clinical and the standard AI and CI and other similar indices.
outcome parameters than the current indices, and be applicable
to both treated and untreated cases.
Methods. A cohort of 71 patients with lupus nephritis who
had initial renal biopsies (Bx1) with systematic second biopsies For over a quarter of a century, pathologists and clini-
(Bx2) at six months after induction therapy was studied, with cians have been attempting to divine patient outcomes
a large number of light microscopic and IF variables evaluated. and the need for continued treatment from the renal
These were examined statistically to choose the combinations
biopsy in lupus nephritis. Pollak, Pirani, and Schwartzof variables with the highest overall correlations with clinical
were the first to distinguish between “active” and scleros-and outcome parameters.
Results. The adopted biopsy index comprised four elements: ing lesions [1]. Morel-Maroger et al in the 1970s system-
Glomerular Activity Index (GAI), a modification of the stan- atized these attempts by dividing lesions into an Activity
dard AI with the addition of glomerular monocytes and elimi-
Index (AI) containing lesions such as cellular crescents,nation of interstitial inflammation; Tubulointerstitial Activity
and a Chronicity Index (CI), composed of glomeruloscle-Index (TIAI), evaluating several tubular epithelial and in-
flammatory components, including interstitial inflammation, rosis and interstitial fibrosis, with different implications
but excluding tubular atrophy; Chronic Lesions Index, a modi- for each index [2]. They were the first to describe, as
fication of the standard CI, with the addition of glomerular others have since confirmed [3–6], that while the AIscars; IF Index (IFI), a semiquantitative index of IF staining
tended to diminish with treatment, the CI tended tofor six standard antisera for glomerular capillary, mesangial,
increase. Austin et al from the NIH refined these con-tubulointerstitial, and vascular elements. The Biopsy Index
showed a statistically higher correlation with clinical and out- cepts with the construction of an AI and CI that have
come parameters than the NIH AI (P 5 0.0170), the NIH CI since become widely accepted [3–16].
(P 5 0.0009), or their combination (P 5 0.0444). At Bx1,
Most investigators have been in agreement that the AI,comparisons between correlation coefficients for the appro-
at least at the initial biopsy, had relatively little predictivepriate AI or CI value and for the Biopsy Index, were: anti-
DNA antibodies (0.30 vs. 045), serum creatinine (SCr; 0.33 vs. power [6, 10, 15, 17, 18]. However, Austin et al found
0.48), proteinuria (0.22 vs. 0.36), hemoglobin (20.21 vs. 20.45), that the CI was moderately predictive of renal survival
and final renal function (0.22 vs. 0.40). Spearman rank correla-
[3, 7, 9]. Their view was supported by other groups who
found good correlations between CI and outcome [8, 12,
15, 18–20]. This view, however, also found detractors who1 See Editorial by Schwartz, p. 1354
either failed to find a good correlation between CI and
Key words: Biopsy Index, NIH Activity Index, Chronicity Index, scle- outcome, or who were dissatisfied that there was no clearrosing lesions, cellular crescents, predictive power of biopsy, inflamma-
tion. cutoff of CI separating those patients who would go into
renal failure from those who would not [6, 14, 17, 21, 22].
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however, that no investigator has been entirely satisfied Technical methods and biopsy data
with these correlations. Specimens for light microscopy were fixed in Bouin’s
We studied a series of 71 patients with initial biopsies fixative, paraffin embedded, sectioned and stained with
and systematic control biopsies at six months after induc- Masson’s trichrome, hematoxylin-eosin, Marinozzi silver
tion of therapy. A number of morphologic variables stain in all cases, and often with periodic acid-Schiff stain.
available from routine biopsy light and immunofluores- Frozen tissue was cut at 4 to 5 mm and incubated with
cence (IF) material were evaluated. Of particular inter- fluoresceinated antisera to human IgG, IgA, IgM, C3,
est, in view of recent evidence suggesting that proteinuria C1q, and fibrinogen. Electron microscopy was not avail-
able on most cases, as it is no longer systematically per-of itself leads to tubular damage and interstitial inflam-
formed in our hospital except for questions of glomerularmation and ultimately to interstitial fibrosis [23–25], was
basement membrane alterations and in other selectedthe development of an index composed of tubular and
cases, since the information supplied is largely duplica-interstitial variables that might shed light on these inter-
tive of light and IF.relationships. Also, particular attention was paid to the
In six cases at Bx1 (though fortunately none at Bx2),different inflammatory elements, including glomerular
there were no glomeruli on the initial light microscopy,monocytes, and tubular inflammatory cells in addition
and the diagnosis of focal or diffuse proliferative lupusto glomerular polymorphonuclear leukocytes (PMNs).
nephritis was established on the basis of paraffin-embed-Finally, IF data were added, since prior morphologic
ded IF material. In these cases, the histologic featuresindices have not included this information.
were often distorted and were inappropriate for detailedThe aim was to find those variables or combinations
morphologic evaluation. Tubular lesions were evaluatedof variables that correlated best with outcome. It also
in the two cases with cortical tubules on original lightseemed very possible that an index developed from un-
microscopy, but not in the four remaining cases.treated cases might not be entirely appropriate for evalu-
Photographs of positive IF were available in 122 (85.9%)ating treated cases, so we tried to find a compromise
of the 142 first and second biopsies, and the biopsy report
applicable to both. A secondary goal was to maximize systematically detailed all results. In 12 biopsies (8.4%),
correlations with clinical parameters at the time of fluorescence photographs were not available, and the
biopsy. It was felt intuitively—and experience subse- report did not permit adequate localization of staining.
quently confirmed—that the best outcome indicators The remaining eight biopsies (5.6%) consisted of only
would have good correlations with the appropriate clini- the medulla.
cal parameters at the time of biopsy. The following clinical parameters were evaluated at
the time of each biopsy: Systemic Lupus Erythematosus
Activity Index (SLEDAI) [26], blood pressure, CH50METHODS
(normal, 60 to 140%), C3 (normal, 750 to 1700 mg/L), C4
Patient population (normal, 150 to 400 mg/L), anti-DNA antibodies (DNA,
normal, ,7 IU/mL), serum creatinine (SCr, mmol/L), pro-Renal biopsies and clinical data from 71 patients from
teinuria (g/24 h), and hematuria (rbc/mL) and hemoglo-four Paris hospitals (Bichat, Broussais, Henri Mondor,
bin (g/dL), and platelets (number/mL). All patients hadand St. Louis) from the period of 1986 to 1994 were
clinical data available for the first and second biopsies,evaluated. All patients had at least four ARA criteria,
but follow-up information as to outcome was incompletewith positive antinuclear and/or anti-DNA preparations
in six patients.in all. The patients had the following demographic distri-
Four somewhat overlapping outcome parameters werebution: 63 females and 8 males; mean age of 36.8 6 13.8
measured: (1) doubling of the initial SCr (CRX2) for threeyears at first biopsy; ethnic origins were 40 Caucasian,
months or more; (2) end-stage renal disease (ESRD),13 North African, 10 Asiatic, and 8 black patients. All
requiring dialysis and/or transplant; (3) renal relapse
patients who had an initial renal biopsy (Bx1) with sys-
(Renrel), recrudescence of renal disease after an initial
tematic second biopsy (Bx2) at six months after induc- therapeutic response, as defined by a recent increase of
tion treatment were included in the study. Subsequent SCr by .50% with active urinary sediment and/or in-
biopsies were performed primarily for clinical indications crease in proteinuria to 3.5 g/day or greater; and (4) final
and are not discussed here, but will be reported in a renal function (RFlast), the last SCr, with an arbitrary value
subsequent communication (manuscript in preparation). of 500 mmol/L assigned to all patients with ESRD who
All biopsies were reviewed by one pathologist (G.S.H.) were on dialysis or transplanted.
who was blind to the clinical data. Cases were categorized
Morphologic variablesaccording to standard WHO criteria [9]. No case of focal
proliferative GN nor of mixed membranous and prolifer- The point of departure in the evaluation of morpho-
logic variables was the schema of AI and CI developed byative GN was diagnosed with fewer than 10 glomeruli.
Hill et al: New biopsy index for lupus nephritis1162
Austin et al [7] and used by them and others in subsequent atrophy that forms a part of the CI. In developing this
index, the following features of tubular damage werepublications [3, 6, 9–16, 22]. Glomerular and tubulointer-
stitial morphologic lesions were graded on a scale of 0 evaluated, all graded according to the percentage of tu-
bular profiles involved:to 31: 0 5 absence of lesions; 11 5 lesions involving
up to 25% of the component considered; 21 5 lesions Tubular nuclear pyknosis (tubpyk). Pyknosis in tubu-
lar epithelium was defined as shrinkage of nuclear pro-involving 25 to 50%; 31 5 lesions involving .50% of
the component. We modified this grading system slightly, files with condensation of the nuclear chromatin.
Tubular nuclear “activation” (tubact). Nuclear “acti-giving a value of 0.51 to lesions that were present, but
minimal (,5 to 10%) in the hope of refining somewhat vation” was defined in cytologic terms by nuclear en-
largement, variation in nuclear size and shape, the pres-the distinctions in the many instances where lesions of
a given type were not widespread. We applied the defini- ence of prominent nucleoli, and irregularities of the
nuclear chromatin (Fig. 1). As best possible, these judg-tions of Austin et al as closely as possible, with one excep-
tion, glomerulosclerosis (discussed later in this article) [7]. ments were based on a comparison of the nuclei in the
affected tubule with those in profiles of the same nephronThe following components of the standard AI were
studied: (1) glomerular proliferation (glprolif), with mono- segment, that is, proximal and distal segments discussed
elsewhere in the section.cyte infiltration distinguished and graded separately (dis-
cussed later in this article); (2) polymorphonuclear leuko- Tubular necrosis (tubnec). Lesions resembling those
in acute tubular necrosis of other causes were often seen.cytes (glpmn); (3) karyorrhexis/fibrinoid necrosis (karyfib);
(4) cellular crescents (cresc); (5) hyaline deposits (hyaldep); Rarely, dead cells with ballooning or karyorrhexis of
nuclei were present. Much more frequently, the lesion(6) interstitial inflammation [intinfl; later removed from
the AI and included with the Tubulointerstitial AI (TIAI), was characterized by detachment and loss of occasional
cells from the basement membrane leaving gaps and bydiscussed later in this article]. As in the standard AI,
karyorrhexis/fibrinoid necrosis and cellular crescents were the disappearance of tubular nuclei over a wide portion
of the circumference of the tubule.weighted by a factor of 2. In addition, the following glo-
merular elements were evaluated: Tubular cell flattening (tubflat). Flattening of the tubu-
lar epithelium was often seen (Fig. 1), sometimes associ-Monocytes in glomerular lumens (glmono). Mono-
cytes and macrophages clearly identifiable as such, either ated with frank tubular necrosis, but also separately with-
out evident necrosis or significant atrophy, as indicatedbecause they lay free in the lumen or because of their
foamy cytoplasm and biconcave nuclei, were considered by tubular basement membrane thickening. It was de-
fined as flattening of the tubular epithelium relative topresent in abnormal quantities if there was more than
one such macrophage per glomerulus. that expected in that nephron segment.
Macrophages in tubular lumens (macrlum). Macro-Membranoproliferative features (MPGN). The pres-
ence of capillary double contours on silver stain was evalu- phages in tubular lumens were identified primarily by
their biconcave nuclei and fairly distinct cell membranes,ated. Cases with only scattered capillary loops showing
double contours were graded 11. Cases with extensive usually with evident cytoplasmic vacuoles and/or inclu-
sions, but occasionally without (Fig. 1). Usually thesedouble contours, resembling membranoproliferative glo-
merulonephritis of other causes, were graded 21. cells were found free in the tubular lumens, but occasion-
ally, they could be found attached to the tubular epithe-The following four components of the standard CI
were evaluated: (1) glomerular sclerosis. In the standard lial cells. Every effort was made to distinguish them from
sloughed epithelial cells, which generally had pyknoticCI two types of glomerular lesions are included under the
heading of glomerular sclerosis. We separated these two nuclei and more eosinophilic cytoplasm with ragged cell
borders, and from so-called “oval fat bodies,” consideredtypes into two categories: (a) glomerular scars (gloscar),
where segmental areas of solidification are found in the conventionally to be desquamated tubular epithelial cells
and filled with generally large fat vacuoles.glomeruli in which other lobules were still intact; (b)
glomerulosclerosis (glscl), where there is total glomerular Epithelial cells in tubular lumens (eplum). Sloughed
tubular epithelial cells in the tubular lumens often hadobsolescence. The glomeruli in each category were counted
separately and scored according to the percentage of the appearance as described for macrophages. Alterna-
tively, they were sometimes small with dense cytoplasmglomeruli involved as discussed previously in this article.
(2) fibrous crescents (fibcres); (3) tubular atrophy (tuba- and might occur in clumps.
Also evaluated, but not included in the TIAI becausetro), for uniformity graded only in the renal cortex; (4)
interstitial fibrosis (intfib), also graded only in the cortex. of poor correlations with clinical and outcome parame-
ters, were tubular cytoplasmic vacuoles, red cells in tubu-Our intent was to develop an index of TIAI that was
analogous to the glomerular components of the AI, iden- lar lumens, PMNs in tubular lumens, tubulitis, and hya-
line casts.tifying those elements that would identify ongoing dis-
ease activity in the tubules, specifically excluding tubular Immunofluorescence data were evaluated in the fol-
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Fig. 1. Tubular lesions in systemic lupus ery-
thematosus (SLE). Tubular nuclear “activa-
tion” (best demonstrated lower right) is re-
vealed by anisocytosis of the nuclei, often with
prominent nucleoli, and occasional mitoses
(arrow). Compare with nuclei of more normal
size (upper center). Numerous tubules show
flattening of cytoplasm, and there are tubules
(center) in which nuclei have disappeared over
a portion of the circumference, a manifesta-
tion of tubular necrosis. Tubular lumenal mac-
rophages are seen in two tubules. Masson tri-
chrome, 3380.
lowing manner. Four separate morphologic components ous variables. In comparing semiquantitative variables,
such as hyaline deposits graded 0 to 31, with continuouswere evaluated: (1) glomerular capillary IF (glcapif), (2)
variables Pearson product-moment correlations wereglomerular mesangial IF (glmesif), (3) vascular IF (vascif),
used. For comparisons of semiquantitative variables withand (4) tubulointerstitial IF (tubulif). (An initial attempt
one another, Spearman rank order correlations werewas made to divide tubulointerstitial staining into tubu-
used. For categorical variables (for example, the pres-lar basement membrane and interstitial staining, but ex-
ence or absence of ESRD), the Spearman rank orderperience rapidly revealed that these two components
correlation test was used.could not be reliably distinguished.) The degree of stain-
In attempting to construct indices, the various combi-ing for each of the six antisera was graded on a scale of
nations of morphologic variables were evaluated in terms0 to 41 for each component, for a total of 24 for each
of their correlations with clinical data at the times ofmorphologic component. Also, the totals for all the anti-
Bx1 and Bx2 and in terms of their power to predict thesera were added for a maximum of 16 for each antiserum.
outcomes chosen. It became apparent early on that noData thus obtained were evaluated in two ways: first
one combination of morphologic variables had the bestaccording to component, for example, glmesif, these be-
combination with all clinical and outcome parametersing the figures used to develop the IFI; second, by totals
simultaneously. In attempting to choose between themfor each antiserum, for example, IgG and IgA.
in the development of a morphologic index, the followingThe following arterial and arteriolar lesions were re-
method was employed: The correlation coefficients for
corded: (1) lesions particularly associated with SLE (bland
all clinical parameters that were significantly correlated
medial necrosis, thrombotic microangiopathy, vasculitis) with any one of the morphologic variables at either
recorded as present or absent; (2) large artery lesions— biopsy were summed, such that the best combination
intimal thickening, intimal cellularity, medial hypertro- had the highest total score. Correlations with RFlast were
phy/hyperplasia, medial fibrosis, graded 0 to 31; (3) small recorded separately. Similarly, the Spearman R values
artery lesions, any combination of the lesion in large for each of the categorical outcome variables (CRX2,
arteries above, graded 0 to 31; and (4) arteriolar lesions, ESRD, Renrel) were summed, once again such that the
that is, the percentage of hyaline arterioles in biopsy. best combination had the highest total score. The overall
results from both biopsies were tallied to assist in deci-
Statistical analyses sion making (Table 5).
For continuous clinical variables (for example, SCr), Comparisons of survival were done by the Kaplan–
Pearson product-moment correlation coefficients were Meier method, with differences in survival curves evalu-
calculated. The various morphologic indices, with maxi- ated by log rank sum testing. Calculations were performed
using Statisticat Version 5 (Statsoft, Inc., Tulsa, OK, USA).mal values ranging from 15 to 96, were treated as continu-
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Table 1. Components of Biopsy IndexRESULTS
Component Symbol ScalePatient material and initial treatment
Glomerular Activity Index (GAI)The initial diagnoses in this series were: diffuse prolif-
Glomerular proliferation glprolif 0–31
erative (WHO Class IV) lupus nephritis, 55 patients; focal Polymorphonuclear leukocytes glpmn 0–31
Karyorrhexis/Fibrinoid necrosis karyfib (0–31)32proliferative (WHO Class III) lupus nephritis, 9 patients;
Cellular crescents cresc (0–31)32and mixed membranous and proliferative (WHO Class
Hyaline deposits hyaldep 0–31
Vc) lupus nephritis, 7 patients. This last was focal (WHO Glomerular monocytes glmono 0–31
Maximum: 24Class Vc) in 4 patients and diffuse (WHO Class Vd) in
Tubulointerstitial Activity Index (TIAI)3 patients.
Tubular cell pyknosis tubpyk 0–31
The six-month induction treatment consisted of monthly Tubular nuclear “activation” tubact 0–31
Tubular cell necrosis tubnec 0–31intravenous cyclophosphamide combined with predni-
Tubular cell flattening tubflat 0–31sone (0.9 6 0.4 mg/kg body wt/day for one month tapered
Macrophages in tubular lumens macrlum 0–31
to 0.4 6 0.1 mg/kg body wt/day at 6 months in 58 patients, Epithelial cells in tubular lumens eplum 0–31
Interstitial inflammation intinfl 0–31and corticosteroids alone in 13 patients (1.4 6 0.3 mg/kg
Maximum: 21body wt/day tapered to 0.5 6 0.16 mg/kg body wt/day Chronic Lesions Index (CI)
at 6 months). Initial treatment was followed at six months Glomerulosclerosis glscl 0–31
Glomerular scars gloscar 0–31by re-evaluation and control renal biopsy to evaluate
Fibrous crescents fibcres 0–31the effects of therapy. Subsequent biopsies were carried Tubular atrophy tubatro 0–31
out primarily for clinical indications. Eighteen patients Interstitial fibrosis intfib 0–31
Maximum: 15eventually doubled their serum creatinine (CRX2), all
Immunofluorescence Index (IFI)of whom had diffuse proliferative (WHO Class IV) lupus Glomerular capillary IF glcapif (0–41)36 antisera
nephritis at initial biopsy. Twelve patients ended in Glomerular mesangial IF glmesif (0–41)36 antisera
Tubulointerstitial IF tubulif (0–41)36 antiseraESRD, with dialysis and/or transplantation, and five pa-
Vascular IF vascif (0–41)36 antiseratients died, of whom three had arrived at CRX2. Maximum: 96
All patients with focal proliferative lupus nephritis
Biopsy Index 5
GAI
8
1
CI
5
1
TIAI
7
1
IFI
32
5 Maximum 12had final renal functions in the normal range. Of the
patients with mixed membranous and proliferative lupus
nephritis, one died of sepsis with marked renal insuffi-
ciency, but had not yet doubled her SCr; the remainder
tween glomerular variables and the TIAI, there were noneshowed normal renal function or mild azotemia.
with the CLI. At Bx2, basically the same correlations
held, but generally to a lesser degree, and there was nowBiopsy index
moderate correlation between the GAI and the CLI.The final Biopsy Index consisted of four components,
However, the glomerular mesangial IF (glmesif) unex-the elements of which are indicated in Table 1: Glomeru-
pectedly failed to show significant correlations with anylar AI (GAI), Tubulointerstitial Activity Index (TIAI),
other morphologic variable and, in fact, correlated nega-Chronic Lesions Index (CLI), and the IF Index (IFI).
tively with most of them. There was virtually no correla-To put the index into proper context, it is preferable first
tion between glcapif and glmesif. No case had capillaryto discuss some of the correlations between morphologic
deposits in the absence of some mesangial deposits, butvariables and clinical parameters, as they have a bearing
there was no correlation whatever between the intensityon the overall development of the index. However, for
of capillary versus mesangial deposits (r 5 20.01 at Bx1simplicity of presentation, the correlations with the indi-
and r 5 0.12 at Bx2), even when cases with membranousces ultimately created, such as the GAI and TIAI, are
features were excluded, nor did glmesif show a significantoften cited in advance of the section dealing with their
correlation with the CI or TIAI at either biopsy.actual development.
Crescents. Cellular crescents behaved in a much dif-
Intrabiopsy morphologic correlations ferent fashion from the other glomerular variables. They
correlated only moderately with other glomerular vari-Glomeruli and glomerular immunofluorescence. At
ables and glomerular capillary IF, but more strongly withBx1, glomerular variables showed generally good corre-
interstitial inflammation, as well as with the chronicitylations among themselves, of which the strongest were
components, particularly interstitial fibrosis, and eventhose of glomerular monocytes with glomerular prolifer-
more strongly with the TIAI, a pattern that was theation (r 5 0.64, P , 0.0001) and with hyaline deposits
reverse of that of hyaline deposits. At Bx2, perhaps be-(r 5 0.56, P , 0.0001). They also correlated well with
cause of the relative infrequence of crescents, these asso-glomerular capillary IF (glcapif), particularly the hyaline
deposits. Although there were moderate correlations be- ciations were no longer evident.
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Table 2. Correlations between serum creatinine and variousInterstitial inflammation. This turned out to be one of
morphologic variables: Pearson product-moment correlations
the pivotal variables. At Bx1, it correlated only moder-
Morphologic variable Biopsy 1 Biopsy 2ately with glomerular variables, but showed extremely
Glomerular variablesstrong correlations with chronicity components and the
Proliferation 0.11 0.22CLI (r 5 0.57, P , 0.0001). Equally strong were the
Glomerular PMNs 0.15 0.18
correlations between interstitial inflammation and the epi- Karyorrhexis/fibrinoid necrosis 0.01 0.09
Crescents 0.40a 0.23thelial and inflammatory components of the TIAI (overall,
Hyaline deposits 0.36a 0.38ar 5 0.56, P , 0.0001). At Bx2, interstitial inflammation
Glomerular monocytes 0.23 0.24a
maintained its high degree of correlation with chronicity MPGN 0.33a 0.26a
Glomerular Activity Index 0.30a 0.33acomponents such as interstitial fibrosis (r 5 0.62, P ,
Tubulointerstitial variables0.0001), and with tubular activity variables and the over-
Tubular nuclear pyknosis 0.30a 0.38aall TIAI (r 5 0.55, P , 0.0001). In part, it was this high
Tubular nuclear “activation” 0.36a 0.60a
degree of correlation with tubular variables that led to Tubular necrosis 0.24a 0.27a
Tubular flattening 0.26a 0.53aits placement in the TIAI, rather than the GAI.
Lumenal macrophages 0.51a 0.44aTubules and tubulointerstitial immunofluorescence.
Lumenal epithelial cells 0.16 0.12
Tubular variables showed generally strong correlations Interstitial inflammation 0.34a 0.52a
Tubulointerstitial Activity Index 0.43a 0.66awith glomerular and chronicity variables. Correlations
Chronicity variablesat Bx1 were excellent between the TIAI and the GAI
Glomerulosclerosis 0.19 0.29a(r 5 0.53, P , 0.0001) and the CLI (r 5 0.55, P , 0.0001),
Glomerular scars 0.31a 0.27a
and the same correlations were obtained to only a slightly Fibrous crescents 0.13 0.04
Tubular atrophy 0.24 0.46alesser extent at Bx2. Correlations between tubular epi-
Interstitial fibrosis 0.28a 0.49athelial variables, interstitial inflammation, and tubuloin-
Chronicity Index 0.31a 0.45a
terstitial IF are discussed later in this article.
Immunofluorescence variables
Chronicity variables. At Bx1 the chronicity variables Glomerular capillary 0.27a 0.30a
Glomerular mesangial 20.29a 20.08correlated principally with interstitial inflammation (dis-
Vascular 0.09 0.32cussed previously in this article), and with tubular lesions.
Tubulointerstitial 0.30a 0.25
Tubular atrophy correlated strongly with epithelial tubu- Immunofluorescence Index 0.11 0.29a
lar lesions (r 5 0.50, P , 0.001) and to a lesser extent a Significant at P , 0.05
with tubulointerstitial IF (r 5 0.44, P , 0.001). However,
correlations between chronicity and glomerular variables
were basically limited to correlations between cellular
and fibrous crescents (r 5 0.33, P , 0.01). The same correlations of complement components with glomerular
IF, although at Bx2 CH50 correlated negatively withgeneral relationships held at Bx2.
both glomerular capillary IF (r 5 20.43, P , 0.01) and
Clinical parameters glomerular mesangial IF (r 5 20.30, P , 0.05). Chronic-
ity and tubular epithelial variables showed no correlationSystemic Lupus Erythematosus Disease Activity Index
(SLEDAI). This index measures the severity of clinical with serum complement, although tubulointerstitial IF
correlated modestly with CH50 at both biopsies (r 5symptomatology of SLE [26]. Correlations with it were
disappointingly limited, consisting only of glomerular 20.28, P , 0.05).
Anti-DNA. Anti-DNA antibodies at Bx1 correlatedmesangial IF (r 5 0.52, P , 0.001) at Bx1. No other
morphologic variable correlated with it at either biopsy. significantly at Bx1 only with glomerular variables, not
with chronicity, tubular or IF variables. The glomerularBlood pressure. The presence of hypertension at Bx1
correlated with the CLI (r 5 0.31, P , 0.05) and the pattern was interesting in that PMNs, monocytes, karyor-
rhexis/fibrinoid necrosis, and crescents all correlated sig-TIAI (r 5 0.33, P , 0.05), and at Bx2 it correlated with
the CLI (r 5 0.33, P 0.05). It correlated best with the nificantly with r values between 0.28 (P , 0.05) and 0.37
(P , 0.01). However, hyaline deposits did not correlateBiopsy Index (r 5 0.41, P , 0.01 at both biopsies).
Interestingly, the correlation with vascular lesions was (r 5 0.12, P 5 NS).
Serum creatinine. Correlations with SCr were strongestlimited to large artery lesions, intimal fibroplasia (r 5
0.34, P , 0.05) and mural fibrosis (r 5 0.41, P , 0.01), with the tubulointerstitial variables at both biopsies, par-
ticularly at Bx2 (Table 2). The TIAI had an excellentand then only at Bx2.
Complement. Correlations were predominantly with correlation with SCr (r 5 0.43, P , 0.001) at Bx1 and (r 5
0.66, P , 0.0001) at Bx2 (rising to r 5 0.71, P , 0.0001,glomerular lesions. Most impressive at first biopsy were
those of CH50 with glomerular proliferation (r 5 20.43, if only diffuse proliferative cases were considered). It
showed stronger correlations than the CLI or its compo-P , 0.001) and with glomerular monocytes (r 5 20.37,
P , 0.01). Interestingly, at Bx1 there were no significant nent, interstitial fibrosis, the elements traditionally asso-
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Table 3. Relationship of morphologic variables to serum creatinine:
Stepwise multiple regression of morphologic indices and all morphologic variables
Multiple regression parameters
Standard
Beta error of beta P R R 2 P
Biopsy 1
Morphologic indices
Tubulointerstitial Activity Index 0.4536 0.1569 0.0059 0.5376 0.2891 ,0.00142
Individual morphologic variables
Macrophages in tubular lumens 0.4520 0.1252 0.00076 0.6762 0.4573 ,0.00001
Glomerular mesangial IF 20.2209 0.1117 0.01
Interstitial fibrosis 0.1619 0.1142 0.16
Biopsy 2
Morphologic indices
Tubulointerstitial Activity Index 0.4611 0.13452 0.0012 0.6259 0.3918 ,0.000001
Chronicity Index 0.2323 0.13452 0.09
Individual morphologic variables
Tubular nuclear “activation” 0.2766 0.1263 0.03 0.7747 0.6002 ,0.000001
Interstitial inflammation 0.2276 0.1109 0.04
Macrophages in lumens 0.2887 0.1026 0.0071
Tubular necrosis 0.2346 0.1108 0.04
Fig. 2. Correlations of indices with serum creatinine (SCr) at the second biopsy (Bx2). Only cases with diffuse proliferative (WHO Class IV)
nephritis are considered. (A) Correlation with the standard (NIH) Chronicity Index (CI). (B) Correlation with the Tubulointerstitial Activity
Index (TIAI). Correlations show a closer fit with the TIAI (r 5 0.7710) than with the NIH CI (r 5 0.4733).
ciated with level of renal function (Fig. 2). Stepwise mul- nent elements: glomerular monocytes at Bx1 and glomer-
ular capillary IF and crescents at Bx2. Less anticipatedtiple regression confirmed these observations (Table 3).
In terms of the morphologic indices, SCr was closely asso- was the positive association of tubular elements with
proteinuria both at Bx1 (tubular nuclear pyknosis) andciated with the TIAI at both biopsies (Table 2). How-
ever, the CLI did not correlate significantly at Bx1 and Bx2 (overall TIAI and tubular flattening), presumably
representing tubular damage related to proteinuria.was of only marginal significance (P 5 0.0902) at Bx2.
Among individual morphologic parameters, the strong- Hematuria. Hematuria showed no significant correla-
tion with any morphologic variable at Bx1, not evenest was the presence of macrophages in tubular lumens,
which was significantly associated at both biopsies. Other karyorrhexis/fibrinoid necrosis (r 5 0.06) or crescents (r 5
20.04). However, at Bx2 there were limited correlationstubulointerstitial parameters, including tubular nuclear
activation, tubular necrosis and interstitial inflammation, with glomerular capillary IF (r 5 0.34, P , 0.05) and
karyorrhexis/fibrinoid necrosis (r 5 0.35, P , 0.05).were significant at Bx2. Interstitial fibrosis was not sig-
nificantly associated with SCr at either biopsy. Among Hemoglobin (Hb). Parallel to the tighter correlation
of SCr with tubulointerstitial lesions than glomerular le-the glomerular variables, by multiple regression only,
glomerular mesangial IF sorted (negatively) at Bx1. sions, Hb levels correlated more closely with tubulointer-
stitial lesions. At Bx1, there was a significant correlationProteinuria. Stepwise multiple regression (Table 4)
revealed that proteinuria was, as anticipated, signifi- between Hb and the TIAI (r 5 20.39, P , 0.01) and
with tubulointerstitial IF (r 5 20.34, P , 0.01), but notcantly associated with the GAI at Bx1, as were its compo-
Hill et al: New biopsy index for lupus nephritis 1167
Table 4. Relationship of morphologic variables to proteinuria:
Stepwise multiple regression of morphologic indices and all morphologic variables
Multiple regression parameters
Standard
Beta error of beta P R R 2 P
Biopsy 1
Morphologic indices
Glomerular Activity Index 0.3090 0.1372 0.03 0.3621 0.1311 ,0.0368
Individual morphologic variables
Glomerular monocytes 0.4786 0.1529 0.0029 0.5233 0.2739 ,0.0014
Tubular nuclear pyknosis 0.3030 0.1303 0.02
Glomerular proliferation 20.2623 0.1544 0.09
Biopsy 2
Morphologic indices
Tubulointerstitial Activity Index 0.4400 0.1459 0.004 0.3925 0.1540 ,0.0153
Glomerular Activity Index 20.1887 0.1459 0.20
Individual morphologic variables
Glomerular capillary IF 0.3821 0.1165 0.0019 0.6159 0.3794 ,0.00002
Cresents 0.2500 0.1148 0.03
Tubular flattening 0.2483 0.1169 0.04
with the GAI (r 5 20.17) nor the CLI (r 5 20.22). At Development of indices
Bx2, the correlation with TIAI was stronger (r 5 20.45, The method for comparing the various candidate com-
P , 0.001), and the GAI now correlated as well (r 5 binations of variables in terms of clinical and outcome
20.43, P , 0.001). The CI, however, showed no signifi- parameters in constructing each of the four indices is in-
cant association with Hb at either time point. dicated in the Methods section. The development of the
Platelets. Correlations between platelets and morpho- CLI is shown as an example of this process in Table 5.
logic variables were extremely limited, confined to glo- The morphologic issues confronted in developing the
merular proliferation (r 5 20.31, P , 0.05) at Bx1 and indices were the following.
vascular IF (r 5 20.30, P , 0.05) and tubulointerstitial (1) As noted previously in this article, interstitial in-
IF (r 5 20.34, P , 0.05) at Bx2. flammation correlated much better morphologically with
the tubular and chronicity variables than with glomerular
Outcome parameters variables. Therefore, one issue was whether correlations
These are discussed at length in another communica- would be better placing interstitial inflammation with
tion (manuscript in preparation), and therefore only a the glomerular components, as in the traditional AI, or
brief summary is given here. At the first biopsy, only to place it with the tubular elements in a tubulointerstitial
vascular IF (P 5 0.02), the quantity of C3 on IF (P 5 AI. The latter solution was ultimately elected, both for
0.002), and more weakly the TIAI (P 5 0.03) and the theoretical reasons in clearly separating the glomerular
Biopsy Index (P 5 0.04) were predictive of CRX2, and from tubulointerstitial lesions, and also because this sep-
none was predictive of ESRD. Furthermore, they had aration improved correlations of the GAI with DNA
such a wide dispersion as to be unhelpful in individual and proteinuria on the one hand and of the TIAI with
cases. At Bx2 the GAI and IFI were predictive, as were SCr on the other.
several of their component variables. For the GAI, these (2) Additionally, since the presence of glomerular
included crescents and karyorrhexis/fibrinoid necrosis. monocytes and MPGN features had been separately re-
Among the IF variables, glomerular capillary IF, tubulo- corded, it was possible to see what influence these might
interstitial IF, vascular IF, and the quantities of IgG have on the correlations of a GAI. Evaluation revealed
and C3 were all predictive. The best predictor of CRX2 that glomerular monocytes strengthened the correlations
among the standard variables was continued presence but MPGN features did not, so they were dropped.
of immune deposits, as reflected by the IFI (R 5 0.4147, (3) In developing a CLI, observations indicated that
P 5 0.0027). Similarly, continued IF deposits at Bx2 fibrous crescents were a relatively weak morphologic
were the only significant predictor of subsequent renal variable, but that glomerular scars were relatively strong,
relapse (R 5 0.4074, P 5 0.0054). The very strongest stronger in fact than glomerulosclerosis in terms of clini-
predictor of CRX2, however, was biopsy inflammation cal parameters. Based on this information, all of the
(R 5 0.5275, P 5 0.000013), a composite variable con- permutations with and without glomerular scars, glomer-
sisting of all of the various inflammatory components, ulosclerosis, and fibrous crescents were tested. In addi-
such as glomerular PMNs and tubular macrophages, in tion, we tested the original CI of Morel-Maroger et al,
containing only glomerulosclerosis and interstitial fibro-the GAI and TIAI.
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Table 5. Chronicity Index candidate combinations
Type of Index [reference]
Present NIH Indices of
Chronicity Chronicity Morel-Maroger
Index Index [5] et al [23] Esdaile Score [12]
Morphologic Glomscl Glomscl Glomscl Glomscl — Glomscl 0—Tubatro & Intfib
components Fibcres Fibcres — — Fibcres — (Intfib only 5 0)
Tubatro Tubatro Tubatro Tubatro Tubatro — 1—Tubatro or Intfib
Intfib Intfib Intfib Intfib Intfib Intfib 2—Intfib & Intinf $1
Gloscar — Gloscar — —
Biopsy 1
Clinicala
SCr 0.31c 0.25c 0.32c 0.26c 0.30c 0.27c 0.16
Proteinuria 0.15 0.12 0.14 0.13 0.18 0.10 0.15
Hemoglobin 20.23 20.21 20.23 20.24 20.20 20.21 20.16
Total 0.69 0.58 0.69 0.63 0.68 0.58 0.47
RFlasta 0.25 0.22 0.24 0.20 0.26 0.21 0.19
Outcomeb
ESRD 0.0590 0.0525 0.0557 0.0518 0.0665 0.0545 0.0972
CRX2 0.1814 0.1810 0.1740 0.1792 0.1723 0.1760 0.1094
Renrelapse 0.1804 0.2077 0.1836 0.2154 0.1451 0.2465 0.0839
Total 0.4208 0.4412 0.4133 0.4464 0.3839 0.4770 0.2905
Biopsy 2
Clinicala
SCr 0.45c 0.43c 0.47c 0.18 20.13 0.43c 0.32
Proteinuria 0.32c 0.31c 0.34c 20.06 20.13 0.30c 0.27c
Hemoglobin 20.25 20.22 20.27c 0.20 0.21 20.18 20.28c
Total 1.02 0.96 1.08 0.32 20.47 0.92 0.87c
RFlasta 0.30c 0.30c 0.27c 0.00 20.24 0.18 0.32c
Outcomeb
ESRD 0.1464 0.1915 0.1250 20.0835 20.1654 0.1101 0.2400c
CRX2 0.1409 0.1773 0.1298 0.0751 20.2012 0.0932 0.2565c
Renrelapse 0.0792 0.0575 0.0752 0.2281 20.1833 0.0938 0.1697
Total 0.3665 0.4263 0.3290 0.2197 20.5499 0.2971 0.6692
Overall (Bx1 1 Bx2)
Clinicala 1.65 1.54 1.77 0.99 0.21 1.50 1.24
RFlasta 0.55 0.52 0.51 0.20 0.02 0.39 0.51
Outcomeb 0.7873 0.8675 0.7423 0.6661 0.1660 0.7741 0.9597
Abbreviations are in the Appendix.
a Pearson product moment correlation
b Spearman rank correlation
c P , 0.05
sis [2]. We also tested a tubulointerstitial index devel- correlations, and PMNs in tubular lumens because of
their rarity. Tubulitis was later eliminated because itoped by Esdaile et al [12]. In their experience, this index
offered the best correlations with outcome of any combi- weakened the correlations.
(5) Among the IF variables, glomerular mesangial IFnation of morphologic parameters.
The best combination of clinical and outcome parame- correlated poorly or negatively with most clinical param-
eters. A comparison of a model containing all four vari-ters was the combination containing all five of the mor-
phologic variables (Table 5). Despite their relatively weak ables with a model eliminating mesangial IF revealed
that, although the latter showed somewhat better corre-clinical correlations, elimination of glomerulosclerosis
or fibrous crescents weakened the overall correlations, lation with clinical parameters, the four-component in-
dex correlated better with RFlast and with outcome pa-particularly with outcome parameters. As Esdaile et al
had found [12], we confirmed that the best overall corre- rameters. Hence, the four-component index was chosen.
lation with outcome parameters was their tubulointersti-
Overall Biopsy Indextial index. However, it had the poorest correlation with
outcome at Bx1 and correlated only poorly with clinical Variations of two basic models were evaluated. The
parameters. first approach (model 1) was to render each biopsy com-
(4) In constructing the TIAI, initial comparison of ponent (GAI, TIAI, CLI, and IFI) equivalent, by divid-
ing each by the numbers of morphologic variables com-the tubular variables studied with clinical and outcome
parameters led to an elimination of red cells in tubular posing it. The second approach (model 2) divided the
morphologic variables into glomerular activity and chro-lumens and hyaline casts because of a lack of significant
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Table 6. Correlation of NIH Activity Index and Chronicity Index with Biopsy Index:
Correlations of clinical and outcome parameters with indices
NIH NIH NIH Present Present
Activity Index [5] Chronicity Index [5] AI 1 CI [5] GAI 1 CLI Biopsy Index
Biopsy 1
CH50 20.15 0.07 20.11 20.16 20.10
DNA 0.31a 0.05 0.28a 0.39a 0.45a
SCr 0.35a 0.25a 0.39a 0.40a 0.49a
Proteinuria 0.24a 0.12 0.25a 0.30a 0.37a
Hematuria 0.02 0.02 0.02 0.02 0.03
Hemoglobin 20.18 20.21 20.22 20.22 20.45a
RFlast 0.11 0.22 0.18 0.21 0.40a
ESRD 20.0025 0.0529 0.0433 0.0668 0.1928
CRX2 0.0618 0.1810 0.1362 0.1319 0.3018a
Renal relapse 20.0123 0.2077 0.1079 0.1190 0.2130
Biopsy 2
CH50 20.25 0.05 20.16 20.13 20.31a
DNA 0.26a 20.22 0.10 0.09 0.14
SCr 0.38a 0.43a 0.49a 0.49a 0.58a
Proteinuria 0.42a 0.31a 0.46a 0.46a 0.44a
Hematuria 0.21 0.07 0.20 0.18 0.23
Hemoglobin 20.43a 20.22 20.44a 20.44a 20.54a
RFlast 0.38a 0.30a 0.43a 0.42a 0.52a
ESRD 0.1323 0.1914 0.2118 0.1868 0.3001a
CRX2 0.2717 0.1773 0.3355a 0.3062a 0.4753a
Renal relapse 0.0955 0.0575 0.1409 0.1677 0.2132
Mean coefficient of determination 0.0634460.06152 0.0387560.04523 0.0711460.07593 0.0807160.07593 0.1314660.10519
P b 0.0170 0.0009 0.0444 0.0882 —
Abbreviations are in the Appendix. All clinical parameters and RFlast evaluated by the Pearson product-moment correlation. ESRD, CRX2, and Renal Relapse
evaluated by Spearman rank correlation. The best correlations for each parameter at each biopsy are indicated in boldface.
a Significant at P , 0.05
b Comparison of mean coefficient of determination (r 2) with that for the Biopsy Index
nicity, and tubulointerstitial activity and chronicity, with ters did approach significance, hemoglobin at Bx1 (P 5
0.0578) and CRX2 at Bx2 (P 5 0.0768)]. However, theoverall activity and chronicity and total biopsy indices
developed from these calculations. Model 2 was the more mean coefficient of determination (r2) for the Biopsy
Index was significantly different from both the NIH AIintellectually pleasing of the two, but it gave inferior re-
sults to model 1 for clinical parameters, and particularly (P 5 0.0170), the NIH CI (P 5 0.0009), and the combina-
tion, NIH AI 1 CI (P 5 0.0444).for outcome parameters, even when various weighting
measures were applied. Therefore, model 1 was chosen.
Comparison with other indicesThe final index is shown in Table 1.
In attempting to find a better correlation between the
Comparison with standard activity and biopsy and outcome parameters, Austin et al proposed
chronicity indices a simplified index involving only cellular crescents as a
measure of activity and interstitial fibrosis as a measureA comparison of the standard AI and CI, and the
sums of the AI 1 CI and the present GAI 1 CLI, with of chronicity [3]. More recently, the same group modified
these criteria somewhat to a new variable they referthe overall Biopsy Index is shown in Table 6, with the
best combination for each parameter at each biopsy indi- to as “high-risk histology” [9]. The high-risk histology
category includes those patients with 50% or more cellu-cated in boldface. The proposed Biopsy Index offers the
best correlations with all four outcome parameters at lar crescents and those with ,50% cellular crescents but
with moderate to severe (2 to 31) interstitial fibrosis.both biopsies. In addition, all clinical parameters signifi-
cantly associated with any one of the indices are shown. Similarly, Esdaile et al developed a tubulointerstitial in-
dex involving tubular atrophy, interstitial fibrosis, andFor five of the six clinical parameters at Bx1 and five of
six parameters at Bx2 (a total of 10 out of 12 possible), interstitial inflammation [12]. In their experience, this
was the best overall predictor of outcome.the correlations were stronger with the Biopsy Index
than with the standard AI and CI or with their sum. We compared our overall index to theirs in terms of
outcome parameters. The results are shown in Table 7.Owing to sample size, for none of the correlation coef-
ficients for individual parameters measured at either Bx1 As can be seen, the Biopsy Index was more predictive
of overall outcome than the index containing crescentsor Bx2 was the Biopsy Index significantly different from
the corresponding NIH AI or CI [although two parame- and interstitial fibrosis of Austin et al [3] or that of
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Table 7. Outcomes: Comparison with other measures of severity
Cresc 1 Intfib High risk Tubulointerstitial Index
Austin et al [5] Austin et al [4] Esdaile et al [12] Biopsy Indexb
Biopsy 1
CRX2a 0.1911 0.1920 0.1094 0.3018d
Renal relapsea 0.0321 0.1363 0.0839 0.2130
ESRDa 0.1505 0.3986 0.0972 0.1925
RFlasta 0.2047 0.0942 0.2031 0.3798d
Prediction of CRX2
Sensitivity 0.3182 0.5000 0.3077 0.3484
Specificity 0.8056 0.7500 0.8095 0.8077
Predictive value 0.3424 0.4937 0.3700 0.3971
Biopsy 2
CRX2a 0.2439 —c 0.2566d 0.4790d
Renal relapsea 20.0761 — 0.1697 0.2276
ESRDa 0.3501d — 0.2400 0.3059d
RFlasta 0.3063d — 0.4302d 0.5799d
Prediction of CRX2
Sensitivity 0.5556 — 0.4000 0.4783
Specificity 0.7593 — 0.8286 0.7368
Predictive ability 0.4692 — 0.4375 0.5279
Abbreviations are in the Appendix. The best correlation for each outcome parameter at each biopsy indicated in boldface.
a Spearman rank correlatin coefficient, R
b Comparisons of values # mean with values . mean
c Four biopsies only at Bx2; results could not be calculated
d Correlation between index and outcome parameter significant at P , 0.05
Esdaile et al [12] involving interstitial fibrosis, tubular outcome parameters, all attempts to do this simply re-
sulted in weakening the overall correlations.atrophy, and interstitial inflammation. The high-risk his-
tology criterion of Austin et al had a very high sensitivity
(0.5556), but was sufficiently restrictive that only eight
DISCUSSIONbiopsies at Bx1 and four at Bx2 qualified [9]. It thus
Development of the individual morphologic indicesidentified only 4 of 18 cases of CRX2.
and the overall Biopsy Index
Vascular lesions Correlations with clinical parameters. One might con-
ceive of a theoretical morphologic variable that wouldVascular lesions are not included in the Biopsy Index.
Therefore, only a summary of their significance in the have no relationship whatever to current clinical parame-
ters and yet predict outcome with some reliability. In-development of an overall biopsy index is given here.
Briefly, those patients with vasculitis at Bx1 (6 patients) deed, we seem to have one—vascular IF at Bx1—that
has no significant correlation with any other morphologichad poorer renal function and worse renal biopsies; how-
ever, the vasculitis healed, and there was no significant or clinical parameter and yet that was prognostic for
CRX2 and ESRD. (It has also been found to be prognos-difference in their outcome compared with those without
arterial lesions. Those patients with thrombotic microan- tic by other investigators [12].) It seems more logical,
however, to expect that morphologic variables predictivegiopathy (9 patients) even more closely approached the
patients without these lesions in terms of biopsy findings of outcome will have good correlations with the appro-
priate clinical parameters at the time of biopsy. This wasand clinical and outcome parameters. The other, nonspe-
cific vascular lesions had a variety of correlations with one of the major points of departure in the development
of the current indices.other morphologic variables, as well as with both clinical
and outcome parameters. However, in almost all in- Surprisingly, little has been written about the correla-
tions of clinical parameters with morphology at the timestances these were weaker than those for the GAI, CI,
and TIAI. Similarly, vascular IF showed no significant of biopsy. Nossent et al found that the AI correlated
with SCr, creatinine clearance and proteinuria, the CI withcorrelation with any other morphologic variable at Bx1,
but did show marginally significant correlations at Bx2 SCr and creatinine clearance, but not proteinuria [18].
Leaker et al had similar results, with the AI and CI bothwith the TIAI (r 5 0.33, P 5 0.0726).
In theoretical terms, it would have seemed desirable correlating with SCr and proteinuria and the AI with
hematuria as well [5]. To our knowledge, this is theto incorporate vascular lesions into the Overall Biopsy
Index. However, because of the relative weakness of extent of such observations in the literature, so that our
series offers new information in this regard.correlations between vascular lesions and clinical and
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The picture that emerges is interesting. Complement of the response to therapy at Bx2, with persistence of
components and DNA correlate predominantly with glo- deposits being highly correlated with CRX2 (R 5 0.48,
merular lesions and very little with tubulointerstitial le- P , 0.001), renal relapse (R 5 0.50, P , 0.001), and
sions or chronicity. At the first biopsy, DNA correlates final renal function (r 5 0.31, P , 0.01).
with the destructive glomerular lesions, crescents and The Biopsy Index also shows better correlations with
karyorrhexis/fibrinoid necrosis and their associated PMNs, clinical and outcome parameters than the alternative
whereas complement components correlate best with en- measures, crescents 1 interstitial fibrosis, proposed by
docapillary proliferation, although both correlate well Austin et al [3], “high risk histology,” also proposed by
with glomerular monocytes. Interestingly, neither DNA Austin et al [9], or the tubulointerstitial index developed
nor complement components correlate significantly with by Esdaile et al [12] (Table 7).
hyaline deposits nor with glomerular IF. Is the Biopsy Index an improvement over current indi-
By contrast, the SCr correlates best with tubulointersti- ces? A legitimate question is whether these improve-
tial components, including tubular epithelial lesions, and ments in correlations are statistically significant over
only to a lesser extent with chronicity components such those of the standard AI and CI. The answer is in part
as interstitial fibrosis (Table 2). This is dealt with in negative. No single difference between the appropriate
greater detail later in this article. Correlations with he- standard AI or CI values and the Biopsy Index reaches
moglobin tend to mirror those of SCr, with good correla- statistical significance. Statistical power calculations re-
tions with the tubulointerstitial components but not with veal the sample size would have to increase from the
glomerular or chronicity variables. present 71 patients to 142 to 374 patients, depending on
Proteinuria showed two sorts of correlations, first with the parameter, for the magnitude of differences in the
glomerular components, particularly glomerular capil- correlation coefficients for any given parameter to reach
lary IF and glomerular monocytes, and second with tubu- significance. However, the mean coefficient of determi-
lar epithelial lesions, presumably as a function of protein- nation (r2) for the Biopsy Index is significantly higher
uria-related damage. Hematuria, by contrast, did not than for the NIH AI, NIH CI, or the combination NIH
show any significant correlations, not even those expected AI 1 CI. In addition, the fact that all four outcome
with crescents and karyorrhexis/fibrinoid necrosis. parameters at both biopsies and five of six clinical param-
Tubulointerstitial Activity Index and Immunofluores- eters at both Bx1 and Bx2 (10 of 12 possible) have
cence Index. Two significant conceptual additions to the stronger correlations with the Biopsy Index makes a
standard AI and CI are the TIAI and the IFI. No other forceful case that the proposed Biopsy Index is a more
series has reported on tubular lesions in this fashion. robust indicator than current indices.
Similarly, although one group has reported on the pres-
It should be pointed out, however, that in the present
ence or absence of IF deposits in the glomeruli [4, 11–13],
series, neither our Biopsy Index nor the NIH AI, CI, orand Banfi et al have reported on their localization within
their combination had adequate predictive power at thethe glomerulus [19], no group has attempted to compart-
time of the first biopsy. The Biopsy Index was marginallymentalize completely and quantitate these lesions.
significant in the prediction of CRX2 (P 5 0.04), butThe TIAI and IFI account for much of the improve-
was not predictive of ESRD. The NIH Indices were notment in correlations with clinical and outcome parame-
predictive of either. At the time of the second biopsy,ters detailed in Table 6. A rough idea of the magnitude
however, the Biopsy Index revealed itself to be a muchof their contribution can be gotten by comparing the
stronger predictor of patient outcome than the standardcolumn labeled “AI 1 CI” with “present GAI 1 CLI”
indices. This will be discussed in detail in a subsequentand, in turn, with the Biopsy Index. Although our revised
communication (manuscript in preparation).GAI and CI make a minor contribution to the improve-
ment in correlations, the bulk of the difference comes Specific morphologic issues
from the addition of the TIAI and the IFI.
Interstitial inflammation. Although continuing to in-The TIAI provides the best measure of the functional
clude interstitial inflammation in the AI, several authorsstatus of the kidney of any of the indices. It shows the
have indicated that conceptually it is more appropriatelystrongest correlations of any index with SCr at both Bx1
considered an indicator of tubulointerstitial activity [3,and Bx2 (Fig. 2B), as well as with the serum hemoglobin,
4, 7, 11–13, 27]. Our study has strengthened this concept.which parallels the SCr. It also shows excellent correla-
Interstitial inflammation showed much closer correla-tions with proteinuria (Table 4). Perhaps because it re-
tions with the chronicity and tubular variables than withflects the functional status of the kidney, the TIAI also
glomerular variables. On multiple regression, interstitialoffers the best correlations with ESRD, CRX2, and RFlast
inflammation was one of the stronger determinants ofat Bx1 before the beginning of treatment. The IFI shows
SCr, particularly at Bx2. Moving it from the GAI to thethe closest correlations with CH50 at both biopsies, but
its primary significance is that it is a strong indicator TIAI strengthened the correlations of the clinical param-
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eters most closely associated with them, DNA and pro- However, we do feel that the addition of tubular and
teinuria for the GAI, and SCr for the TIAI. IF variables to the indices is conceptually important, par-
Glomerular capillary versus glomerular mesangial im- ticularly as they relate to the correlation of tubular epithe-
munofluorescence. The finding that there was essentially lial lesions with SCr and proteinuria, and the prognostic
no correlation between glomerular capillary and glomer- importance of persistence of immune deposits on IF and
ular mesangial IF in this study was totally unexpected. of inflammation at Bx2. Issues of reproducibility aside,
For many years, it has been generally believed that de- these basic concepts regarding the significance of tubular
posits occur first in the mesangium and only later in the lesions and the importance of persistent immune deposits
subendothelial space when the mesangium is over- and inflammation should have the same sort of applica-
whelmed [28, 29], and it is on this basic concept that the bility in day-to-day practice as the ideas of activity versus
current classification of lupus nephritis is based. One chronicity expressed in the traditional AI and CI. Like
would have anticipated that glomerular mesangial IF the standard NIH Indices, the greatest value of the new
would show the same general correlations with clinical Biopsy Index will lie in the systematic evaluation of an
and outcome parameters as glomerular capillary IF, per- entire series of patients. We feel that the inclusion of the
haps in weaker, less significant form. While it was true new parameters will serve to focus attention on aspects
that no case in our series had capillary wall deposits of the morphological picture that have hitherto been
without mesangial deposits, there was no further correla- underemphasized in our thinking about lupus nephritis,
tion between the two in terms of intensity (r 5 0.011 at its pathogenesis, and the evaluation of the results of
Bx1). They actually correlated in different directions for therapy.
several parameters, most notably SCr.
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only glomerular capillary IF at Bx2 is significantly corre-
Abbreviations used in this article are: AI, NIH Activity Index; Bx1,
lated with CRX2 (R 5 0.34, P , 0.05); glomerular mes- first biopsy; Bx2, second biopsy; CI, Chronicity Index; cresc, cellular
angial IF is not. However, parallel with our observation crescents; CLI, Chronic Lesions Index; CRX2, doubling of the initial
serum creatinine; eplum, epithelial cells in tubular lumens; ESRD, end-that persistent immune deposits on the IFI at Bx2 are a
stage renal disease; fibcres, fibrous crescents; GAI, Glomerular Activitystrong predictor of poor outcome, Esdaile et al found Index; glcapif, glomerular capillary immunofluorescence; glmesif, glo-
that persistence of subendothelial deposits on EM at merular mesangial cell immunofluorescence; glmono, monocytes in
glomerular lumens; gloscar, glomerular scars; glpmn, glomerular prolif-Bx2 also predicts poor outcome [13].
eration of polymorphonuclear leukocytes; glprolif, glomerular prolifer-
ation; glscl, glomerulosclerosis; hyaldep, hyaline deposits; IF, immuno-Potential value of Biopsy Index
fluorescence; IFI, Immunofluorescence Index; intfib, interstitial fibrosis;
intinfl, interstitial inflammation; karyfib, karyorrhexis/fibrinoid necro-Objections have been raised concerning the reproduc-
sis; macrlum, macrophages in tubular lumens; MPGN, membranoprolif-ibility of the standard AI and CI [30, 31]. Although some
erative glomerulonephritis; NIH, National Institutes of Health; PMNs,
observers have found excellent reproducibility for the polymorphonuclear leukocytes; Renrel, renal relapse; RFlast, final renal
function; SCr, serum creatinine; SLEDAI, Systemic Lupus Erythemato-AI and CI [27], Schwartz et al found that there was poor
sus Activity Index; TIAI, Tubulointerstitial Activity Index; tubact, tu-interobserver and intraobserver reproducibility [30], as
bular nuclear activation; tubatro, tubular atrophy; tubflat, tubular celldid Wernick et al, who found agreement between pairs flattening; tubnec, tubular necrosis; tubpyk, tubular nuclear pyknosis;
of pathologists within one point for chronicity and two tubulif, tubulointerstitial immunofluorescence; vascif, vascular immu-
nofluorescence; WHO, World Health Organization.points for activity in only 50% of cases [31]. There is
no reason to think that these new indices will be more
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